Formation Bio has launched a $600 million fund to acquire [...]
Researchers at ETH Zurich have developed an electrically powered implant [...]
Laverock Therapeutics is expanding its therapeutic pipeline into in vivo [...]
Eleva is separating its moss-based biologics platform from its clinical-stage [...]
Fuse Diagnostics has raised £1 million to scale manufacturing and [...]
A systematic review of more than two decades of clinical [...]
Circio is preparing to advance its circular RNA gene therapy [...]
HAYA Therapeutics has received FDA Fast Track designation for HTX-001, [...]
Mission Therapeutics has signed a deal worth up to US$292 [...]
Latent Labs has launched its artificial intelligence-powered drug design platform [...]